Ying-Tai Jin Selected Research

Folic Acid Deficiency (Folic Acid Deficiencies)

4/2022	Anemia, hematinic deficiencies, and hyperhomocysteinemia in male and female burning mouth syndrome patients.
1/2022	Anemia, hematinic deficiencies, and hyperhomocysteinemia in burning mouth syndrome patients with thyroglobulin antibody/thyroid microsomal antibody positivity but without gastric parietal cell antibody positivity.
1/2022	Higher gastric parietal cell antibody titer significantly increases the frequencies of macrocytosis, serum vitamin B12 deficiency, and hyperhomocysteinemia in patients with burning mouth syndrome.
1/2022	Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in burning mouth syndrome patients with normocytosis.
12/2021	Higher serum homocysteine level and frequency of hyperhomocysteinemia in carcinoembryonic antigen-positive or squamous cell carcinoma-antigen-positive oral leukoplakia patients.
10/2021	Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in burning mouth syndrome patients with macrocytosis.
10/2021	Anemia, hematinic deficiencies, and hyperhomocysteinemia in serum gastric parietal cell antibody-positive burning mouth syndrome patients without serum thyroid autoantibodies.
3/2021	Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in burning mouth syndrome patients with or without microcytosis.
3/2020	Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in burning mouth syndrome patients with iron deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying-Tai Jin Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 04/2004
10	Hyperhomocysteinemia 04/2022 - 03/2020
9	Anemia 04/2022 - 03/2020
9	Folic Acid Deficiency (Folic Acid Deficiencies) 04/2022 - 03/2020
8	Burning Mouth Syndrome (Syndrome, Burning Mouth) 04/2022 - 03/2020
7	Squamous Cell Carcinoma of Head and Neck 12/2014 - 04/2005
6	Mouth Neoplasms (Oral Cancer) 12/2014 - 10/2002
6	Nasopharyngeal Carcinoma 10/2010 - 03/2003
5	Neoplasm Metastasis (Metastasis) 07/2011 - 04/2008
4	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2022 - 03/2020
4	Carcinoma (Carcinomatosis) 10/2020 - 03/2011
4	Carcinogenesis 12/2014 - 04/2004
2	Iron Deficiencies 03/2021 - 03/2020
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2012 - 06/2010
2	Disease Progression 06/2010 - 04/2006
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2008 - 08/2006
2	Inflammation (Inflammations) 04/2005 - 12/2002
1	Oral Leukoplakia 12/2021
1	Radicular Cyst 10/2021
1	Calcifying Epithelial Odontogenic Tumor 07/2021
1	Erythema Multiforme 01/2021
1	Pernicious Anemia 03/2020
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 03/2020
1	Adenoid Cystic Carcinoma (Cylindroma) 12/2018
1	Sarcoma (Soft Tissue Sarcoma) 07/2011
1	Melanoma (Melanoma, Malignant) 07/2011
1	Lymphoma (Lymphomas) 09/2010
1	Adenocarcinoma of Lung 03/2009
1	Colonic Neoplasms (Colon Cancer) 08/2005
1	Arthritis (Polyarthritis) 04/2005
1	Bacteremia 05/2004
1	Streptococcal Infections (Streptococcal Infection) 05/2004

Drug/Important Bio-Agent (IBA)

9	IronIBA 04/2022 - 03/2020
9	HematinicsIBA 04/2022 - 03/2020
9	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2022 - 03/2020
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2021
5	Messenger RNA (mRNA)IBA 12/2018 - 04/2004
3	Folic Acid (Vitamin M)FDA LinkGeneric 04/2022 - 03/2020
3	Galectin 1 (LGALS1)IBA 03/2011 - 04/2008
2	HomocysteineIBA 04/2022 - 12/2021
2	Thyroglobulin FDA Link 01/2022 - 10/2021
2	AntibodiesIBA 01/2022 - 10/2002
2	Coloring Agents (Dyes)IBA 12/2012 - 12/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 10/2002
2	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 03/2011 - 03/2009
2	Small Interfering RNA (siRNA)IBA 03/2011 - 03/2009
2	Proteins (Proteins, Gene)FDA Link 04/2008 - 04/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 10/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2006 - 04/2006
2	HLA-A Antigens (HLA-A)IBA 07/2005 - 03/2003
1	squamous cell carcinoma-related antigenIBA 12/2021
1	Carcinoembryonic AntigenIBA 12/2021
1	HemosiderinIBA 10/2021
1	MetalsIBA 10/2021
1	AutoantibodiesIBA 10/2021
1	Congo RedIBA 07/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2021
1	Propolis (Bee Bread)IBA 01/2021
1	Monoclonal AntibodiesIBA 10/2020
1	human ERBB2 proteinIBA 10/2020
1	VitaminsIBA 03/2020
1	CateninsIBA 12/2014
1	MicroRNAs (MicroRNA)IBA 12/2014
1	Arginine (L-Arginine)FDA Link 12/2012
1	arginine deiminaseIBA 12/2012
1	Amino Acids FDA Link 12/2012
1	Pharmaceutical PreparationsIBA 12/2012
1	FormazansIBA 12/2012
1	IntegrinsIBA 07/2011
1	CollagenIBA 07/2011
1	Laminin (Merosin)IBA 07/2011
1	Fibronectins (Fibronectin)IBA 07/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2011
1	Conditioned Culture MediaIBA 03/2011
1	LigandsIBA 10/2010
1	Chemokine CCL20IBA 06/2010
1	Cadherins (E-Cadherin)IBA 04/2010
1	beta CateninIBA 04/2010
1	Tumor Biomarkers (Tumor Markers)IBA 04/2010
1	integrin alphavbeta6IBA 02/2010
1	Cyclic PeptidesIBA 02/2010
1	Peptides (Polypeptides)IBA 02/2010
1	Oncogene Proteins (Oncogene Protein)IBA 05/2009
1	Matrix Metalloproteinases (MMPs)IBA 03/2009
1	Monomeric GTP-Binding ProteinsIBA 03/2009
1	Galectins (Galectin)IBA 03/2009
1	AgarIBA 08/2006
1	GelsolinIBA 07/2006
1	AmphiregulinIBA 04/2006
1	CarcinogensIBA 04/2006
1	Tyrosine (L-Tyrosine)FDA Link 08/2005
1	Phosphotransferases (Kinase)IBA 08/2005
1	Focal Adhesion Protein-Tyrosine KinasesIBA 08/2005
1	Butyrates (Butyrate)IBA 08/2005
1	Dietary Fiber FDA Link 08/2005
1	kallistatinIBA 04/2005

Therapy/Procedure

2	Therapeutics 12/2012 - 10/2010
1	Decompression 09/2010
1	Laminectomy 09/2010
1	Radiotherapy 07/2008